Literature DB >> 9029784

Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies.

I M Antón1, S González, M J Bullido, M Corsín, C Risco, J P Langeveld, L Enjuanes.   

Abstract

Following infection of haplotype defined NIH-miniswine with virulent transmissible gastroenteritis coronavirus (TGEV), isolated mesenteric lymph node CD4+ T-cells mounted a specific proliferative response against infectious or inactivated purified virus in secondary in vitro stimulation. A specific, dose-dependent response to the three major recombinant viral proteins: spike (S), membrane (M), and nucleoprotein (N), purified by affinity chromatography, was characterized. Induction of in vitro antibody synthesis was analyzed. The purified recombinant viral proteins induced the in vitro synthesis of neutralizing TGEV-specific antibodies when porcine TGEV-immune cells were stimulated with each of the combinations made with two of the major structural proteins: S + N, S + M, and to a minor extent with M + N, but not by the individual proteins. S-protein was dissociated from purified virus using NP-40 detergent and then micellar S-protein oligomers (S-rosettes) were formed by removing the detergent. These occurred preferentially by the association of more than 10 S-protein trimmers. These S-rosettes in collaboration with either N or M-proteins elicited TGEV-specific antibodies with titers up to 84 and 60%, respectively, of those induced by the whole virus. N-protein could be partially substituted by a 15-mer peptide that represents a T helper epitope previously identified in N-protein (Antón et al. (1995)). These results indicate that the induction of high levels of TGEV-specific antibodies requires stimulation by at least two viral proteins, and that optimum responses are induced by a combination of S-rosettes and the nucleoprotein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029784      PMCID: PMC7134021          DOI: 10.1016/s0168-1702(96)01390-1

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  56 in total

1.  Transplantation in miniature swine. I. Fixation of the major histocompatibility complex.

Authors:  D H Sachs; G Leight; J Cone; S Schwarz; L Stuart; S Rosenberg
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

2.  Efficacy of isolated colostral IgA, IgG, and IgM(A) to protect neonatal pigs against the coronavirus of transmissible gastroenteritis.

Authors:  S S Stone; L J Kemeny; R D Woods; M T Jensen
Journal:  Am J Vet Res       Date:  1977-09       Impact factor: 1.156

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Genetic basis for the pathogenesis of transmissible gastroenteritis virus.

Authors:  R D Wesley; R D Woods; A K Cheung
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Antigenic structure of transmissible gastroenteritis virus. I. Properties of monoclonal antibodies directed against virion proteins.

Authors:  H Laude; J M Chapsal; J Gelfi; S Labiau; J Grosclaude
Journal:  J Gen Virol       Date:  1986-01       Impact factor: 3.891

6.  Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs.

Authors:  J L VanCott; T A Brim; R A Simkins; L J Saif
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

7.  Antigenicity of the peplomer protein of infectious bronchitis virus.

Authors:  J A Lenstra; J G Kusters; G Koch; B A van der Zeijst
Journal:  Mol Immunol       Date:  1989-01       Impact factor: 4.407

8.  Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein.

Authors:  A M Boots; B J Benaissa-Trouw; W Hesselink; E Rijke; C Schrier; E J Hensen
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Complete sequence (20 kilobases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus.

Authors:  J F Eleouet; D Rasschaert; P Lambert; L Levy; P Vende; H Laude
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

10.  Induction of protective immunity against coronavirus-induced encephalomyelitis: evidence for an important role of CD8+ T cells in vivo.

Authors:  E Flory; M Pfleiderer; A Stühler; H Wege
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

View more
  20 in total

1.  Construction of a bivalent DNA vaccine co-expressing S genes of transmissible gastroenteritis virus and porcine epidemic diarrhea virus delivered by attenuated Salmonella typhimurium.

Authors:  Yudi Zhang; Xiaohui Zhang; Xiaodan Liao; Xiaobo Huang; Sanjie Cao; Xintian Wen; Yiping Wen; Rui Wu; Wumei Liu
Journal:  Virus Genes       Date:  2016-03-15       Impact factor: 2.332

2.  Effects of infection with transmissible gastroenteritis virus on concomitant immune responses to dietary and injected antigens.

Authors:  Michael Bailey; Karin Haverson; Bevis Miller; Philip Jones; Isabel Sola; Luis Enjuanes; Christopher R Stokes
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

3.  Characterization of an Immunodominant Epitope in the Endodomain of the Coronavirus Membrane Protein.

Authors:  Hui Dong; Xin Zhang; Hongyan Shi; Jianfei Chen; Da Shi; Yunnuan Zhu; Li Feng
Journal:  Viruses       Date:  2016-12-10       Impact factor: 5.048

4.  Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

Authors:  Yiu Wing Kam; François Kien; Anjeanette Roberts; Yan Chung Cheung; Elaine W Lamirande; Leatrice Vogel; Shui Ling Chu; Jane Tse; Jeannette Guarner; Sherif R Zaki; Kanta Subbarao; Malik Peiris; Béatrice Nal; Ralf Altmeyer
Journal:  Vaccine       Date:  2006-08-22       Impact factor: 3.641

5.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

6.  A recombinant nucleocapsid protein-based indirect enzyme-linked immunosorbent assay to detect antibodies against porcine deltacoronavirus.

Authors:  Mingjun Su; Chunqiu Li; Donghua Guo; Shan Wei; Xinyu Wang; Yufei Geng; Shuang Yao; Jing Gao; Enyu Wang; Xiwen Zhao; Zhihui Wang; Jianfa Wang; Rui Wu; Li Feng; Dongbo Sun
Journal:  J Vet Med Sci       Date:  2015-12-13       Impact factor: 1.267

7.  Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production.

Authors:  Heng Yang; Sanjie Cao; Xiaobo Huang; Jiawen Liu; Ying Tang; Xintian Wen
Journal:  Vaccine       Date:  2009-06-30       Impact factor: 3.641

Review 8.  SARS vaccines: where are we?

Authors:  Rachel L Roper; Kristina E Rehm
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

9.  A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

Authors:  Naomi Takasuka; Hideki Fujii; Yoshimasa Takahashi; Masataka Kasai; Shigeru Morikawa; Shigeyuki Itamura; Koji Ishii; Masahiro Sakaguchi; Kazuo Ohnishi; Masamichi Ohshima; Shu-ichi Hashimoto; Takato Odagiri; Masato Tashiro; Hiroshi Yoshikura; Toshitada Takemori; Yasuko Tsunetsugu-Yokota
Journal:  Int Immunol       Date:  2004-08-16       Impact factor: 4.823

10.  Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model.

Authors:  Hui Hu; Xianqing Huang; Ling Tao; Yi Huang; Bao-An Cui; Hanzhong Wang
Journal:  Vaccine       Date:  2009-01-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.